i
Updates to the Evidence to Recommendation Framework : 2nd COVID-19 booster dose in adults ages 50 years and older and immunocompromised individuals
-
April 20, 2022
Series: ACIP meeting COVID-19 Vaccines
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subject:
-
Series:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +